Education
About Us
Working with TipRanks
Follow Us
Lifeward (LFWD)
NASDAQ:LFWD
Earnings Data
Report Date
May 08, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.33Last Year’s EPS
-0.73Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 07, 2025
|% Change Since: -8.23%
|Next Earnings Date:May 08, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted significant revenue growth and strategic partnerships, coupled with operational improvements. However, challenges such as ReWalk sales not meeting expectations, a decrease in gross margin, and financial health concerns tempered the positive aspects.Company Guidance
In the Lifeward Inc. fourth quarter 2024 earnings call, the company provided guidance for 2025, highlighting key metrics and strategic directions. Lifeward expects full-year revenue to range between $28 million and $30 million, with an adjusted gross margin between 47% and 49%. The company aims to reduce full-year non-GAAP operating expenses to $22 million to $23 million, down from $27.5 million in 2024, driving a non-GAAP operating loss of $7 million to $9 million. The focus for 2025 includes achieving a quarterly operating loss at or below $1 million by Q4, driven by targeted growth in high-margin opportunities and operating efficiencies. The strategic initiatives for 2025 involve expanding ReWalk placements with CMS, penetrating the workers' compensation market, and enhancing distribution for the MyoCycle and AlterG products. The company also plans to implement a sustainable growth plan to optimize product mix, reduce costs, and maintain disciplined spending to reach its financial goals.Record Revenue Achievement
Lifeward reported record quarterly revenue of $7.5 million in Q4 2024, contributing to an 85% annual revenue growth for the year, reaching $25.7 million.
Operational Efficiency Improvements
The company increased operating efficiency by closing two locations and reducing headcount by 35% as part of their sustainable growth plan.
Strategic Partnerships and Market Expansion
Lifeward entered a meaningful contract with BARMER in Germany, expanded MyoCycle distribution rights, and launched a national accounts program for AlterG.
New Product Launches
The company launched a new generation of AlterG (NEO product) and completed FDA usability studies for ReWalk 7.
---
LFWD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
LFWD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 07, 2025 | $1.58 | $1.63 | +3.16% |
| Nov 12, 2024 | $2.37 | $2.39 | +0.84% |
| Aug 15, 2024 | $3.12 | $4.07 | +30.45% |
| May 15, 2024 | $5.19 | $5.05 | -2.70% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Lifeward (LFWD) report earnings?
Lifeward (LFWD) is schdueled to report earning on May 08, 2025, TBA Not Confirmed.
What is Lifeward (LFWD) earnings time?
Lifeward (LFWD) earnings time is at May 08, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LFWD EPS forecast?
LFWD EPS forecast for the fiscal quarter 2025 (Q1) is -0.33.
---